Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-27

Clinical Trial Update: PRP Use in Diabetic Patients Undergoing Cesarean Section [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes the use of platelet-rich plasma in gestational diabetes patients undergoing cesarean section, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (PRP)

Snippet

Sponsor: Minia University | Conditions: Diabetes, Gestational, Wound Complication | Phase 2, Phase 3 | Status: UNKNOWN